Portfolio (Quarterly)
Guide ↗
Soleus Capital Management, L.P.
· CIK 0001802630| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | ALNY | ALNYLAM PHARMACEUTICALS INC | Healthcare | 33,050.0 | $9.9M | 0.34% | -99K | -74.9% | $301.03 | -20.6% |
| 22 | SOPH | SOPHIA GENETICS SA | Healthcare | 1,565,000.0 | $9.0M | 0.31% | -285K | -15.4% | $5.77 | +47.8% |
| 23 | MIRM | MIRUM PHARMACEUTICALS INC | Healthcare | 75,000.0 | $8.8M | 0.30% | -325K | -81.3% | $117.07 | -15.9% |
| 24 | TNDM | TANDEM DIABETES CARE INC | Healthcare | 575,000.0 | $8.7M | 0.30% | -208K | -26.6% | $15.09 | +41.6% |
| 25 | ELVN | ENLIVEN THERAPEUTICS INC | Healthcare | 165,677.0 | $8.4M | 0.29% | -65K | -28.2% | $50.75 | +19.9% |
| 26 | SION | SIONNA THERAPEUTICS INC | Healthcare | 177,687.0 | $7.8M | 0.27% | -116K | -39.5% | $43.99 | -86.0% |
| 27 | CERS | CERUS CORP | Healthcare | 2,500,000.0 | $7.3M | 0.25% | -8.3M | -76.8% | $2.92 | -6.2% |
| 28 | MRK | MERCK & CO INC | Healthcare | 50,000.0 | $6.4M | 0.22% | -153K | -75.4% | $128.50 | +19.2% |
| 29 | EOLS | EVOLUS INC | Healthcare | 822,428.0 | $5.7M | 0.20% | -1.4M | -63.4% | $6.94 | +26.5% |
| 30 | — | SAB BIOTHERAPEUTICS INC | — | 900,000.0 | $3.5M | 0.12% | -150K | -14.3% | $3.90 | — |
| 31 | TECX | TECTONIC THERAPEUTIC INC | Healthcare | 101,684.0 | $3.5M | 0.12% | -20K | -16.4% | $34.38 | +4.6% |
| 32 | AXGN | AXOGEN INC | Healthcare | 57,036.0 | $2.6M | 0.09% | -622K | -91.6% | $46.19 | +11.7% |
| 33 | MSLE | SATELLOS BIOSCIENCE INC | Healthcare | 314,359.0 | $2.4M | 0.08% | -100K | -24.1% | $7.78 | +20.4% |
| 34 | CORT | CORCEPT THERAPEUTICS INC | Healthcare | 19,653.0 | $1.7M | 0.06% | -266K | -93.1% | $86.95 | +37.8% |
| 35 | VCYT | VERACYTE INC | Healthcare | 25,000.0 | $1.5M | 0.05% | -295K | -92.2% | $58.73 | -24.6% |
| 36 | CGEM | CULLINAN THERAPEUTICS INC | Healthcare | 50,000.0 | $910K | 0.03% | -360K | -87.8% | $18.21 | +25.5% |
| 37 | IOVA | IOVANCE BIOTHERAPEUTICS INC | Healthcare | 150,000.0 | $624K | 0.02% | -850K | -85.0% | $4.16 | +94.2% |
| 38 | LRMR | LARIMAR THERAPEUTICS INC | Healthcare | 188,102.0 | $574K | 0.02% | -879K | -82.4% | $3.05 | +36.7% |
| 39 | CGON | CG ONCOLOGY INC | Healthcare | 5,000.0 | $355K | 0.01% | -15K | -75.0% | $71.05 | +10.4% |
| 40 | NTRA | NATERA INC | Healthcare | 1,000.0 | $271K | 0.01% | -118K | -99.2% | $271.45 | +24.7% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%